Cholera (Vibrio cholerae)
For the why behind the fact
Use this page to connect what you are memorizing.
Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.
Overview
Plain-Language Overview
Cholera spreads when people ingest food or water contaminated with toxin-producing Vibrio cholerae. Many infections cause few or no symptoms. In severe illness, sudden watery diarrhea and vomiting can cause life-threatening fluid loss within hours. Prompt replacement of water and salts is lifesaving.
Clinical Definition
Epidemic cholera is a small-intestinal infection caused by toxigenic Vibrio cholerae O1 or O139. The toxin drives chloride and water secretion without invading the mucosa. Most infections are asymptomatic or mild, but profuse rice-water stools can rapidly cause dehydration and hypovolemic shock. Glucose-coupled sodium absorption persists, which is why oral rehydration solution works even while diarrhea continues.
Inciting Event
Ingestion of water or food contaminated with toxigenic Vibrio cholerae is the inciting event.
Exposure often occurs during floods or natural disasters disrupting water sanitation.
Consumption of raw or undercooked seafood from contaminated sources can trigger infection.
Latency Period
Symptoms generally begin 12 hours to 5 days after ingestion.
Many exposed people remain asymptomatic. In severe illness, major fluid losses can occur within hours after diarrhea starts.
Diagnostic Delay
Early symptoms may be mistaken for other causes of acute diarrhea such as viral gastroenteritis.
Limited access to stool testing can delay outbreak confirmation. Begin rehydration from the clinical assessment immediately.
Mild or asymptomatic cases may not seek medical attention, delaying outbreak recognition.
Clinical Presentation
Signs & Symptoms
Profuse watery diarrhea described as 'rice-water stools' without blood or pus
Severe dehydration symptoms including thirst, weakness, and dizziness
Vomiting often accompanies diarrhea
Muscle cramps due to electrolyte loss
Hypotension and tachycardia from volume depletion
History of Present Illness
Abrupt onset of profuse watery diarrhea described as 'rice-water stools' is characteristic.
Rapid progression to dehydration with symptoms of thirst, weakness, and muscle cramps occurs.
Vomiting often accompanies diarrhea early in the illness.
Patients may report exposure to contaminated water or recent travel to endemic areas.
Past Medical History
Previous episodes of cholera or other diarrheal illnesses may be noted.
History of immunosuppression or malnutrition increases risk of severe disease.
Lack of prior cholera vaccination is relevant in endemic regions.
Family History
Cholera is an acquired infection. Blood group O is associated with more severe disease among infected people.
Family members may share exposure risks due to common water sources or living conditions.
Physical Exam Findings
Dehydration signs including dry mucous membranes and decreased skin turgor
Hypotension and tachycardia due to volume depletion
Sunken eyes and cold extremities indicating severe hypovolemia
Delayed capillary refill and cool extremities can indicate poor peripheral perfusion.
Muscle cramps from electrolyte imbalances
Diagnostic Workup
Diagnostic Criteria
Suspect cholera with acute watery diarrhea and compatible exposure. Assess dehydration and initiate rehydration immediately. Stool culture with O1/O139 serogrouping or appropriate PCR supports laboratory confirmation. Establish toxigenicity when indicated by the epidemiologic setting. Rapid antigen tests can flag a possible outbreak but require confirmatory testing.
Pathophysiology
Key Mechanisms
The B subunits of the AB5 toxin bind GM1 ganglioside on enterocytes. The A1 fragment ADP-ribosylates Gsα, impairing GTP hydrolysis and maintaining the active GTP-bound state. Adenylyl cyclase activity and intracellular cAMP rise.
cAMP activates protein kinase A, which increases CFTR-mediated chloride secretion. Water follows electrolytes into the intestinal lumen.
The result is secretory diarrhea that persists during fasting. Apical sodium-glucose cotransport through SGLT1 still absorbs sodium with glucose, and water follows.
Stool bicarbonate loss causes a normal-anion-gap metabolic acidosis. If hypovolemic shock impairs tissue perfusion, lactic acidosis can add a high-anion-gap component.
| Involvement | Details |
|---|---|
| Organs | Small intestine is the main organ involved in cholera pathogenesis, where the cholera toxin disrupts electrolyte and water absorption. |
Kidneys are critical organs affected secondarily due to dehydration and electrolyte imbalances caused by cholera-induced diarrhea. | |
| Tissues | Intestinal mucosa is the primary tissue affected by Vibrio cholerae infection, where toxin-induced secretion causes profuse diarrhea. |
| Cells | Enterocytes are the intestinal epithelial cells targeted by cholera toxin, leading to increased chloride secretion and watery diarrhea. |
Absorptive enterocytes retain sodium-glucose cotransport during toxin-induced secretion. Glucose and salts supplied together improve net water absorption. | |
| Chemical Mediators | Cholera toxin activates adenylate cyclase in enterocytes, increasing cyclic AMP and causing chloride and water secretion. |
cAMP is the key intracellular mediator elevated by cholera toxin that drives secretory diarrhea. |
Treatments
Pharmacological Treatments
Doxycycline
- Mechanism:
Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit of Vibrio cholerae.
- Side effects:
Gastrointestinal upset
Photosensitivity
Dental staining is a concern with older tetracyclines or prolonged exposure during tooth development. It is not a blanket reason to withhold single-dose doxycycline in severe cholera.
- Clinical role:
Adjunct to rehydration for severe cholera and selected high-risk patients. A susceptible strain may be treated with a single dose under local guidance.
Azithromycin
- Mechanism:
Macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit of Vibrio cholerae.
- Side effects:
Gastrointestinal upset
QT prolongation
Allergic reactions
- Clinical role:
An alternative adjunct for indicated cases when local susceptibility and patient factors support its use. Begin fluid replacement immediately.
Tetracycline
- Mechanism:
Bacteriostatic antibiotic that inhibits protein synthesis by binding to the 30S ribosomal subunit of Vibrio cholerae.
- Side effects:
Photosensitivity
Gastrointestinal upset
Tooth discoloration in children
- Clinical role:
Tetracycline is an older susceptible-strain option with age- and pregnancy-related precautions. Follow current local guidance for agent selection.
Non-pharmacological Treatments
Give correctly prepared oral rehydration solution (ORS) promptly to patients who can drink. Replace ongoing losses and reassess hydration frequently.
Severe dehydration or shock requires immediate IV isotonic crystalloid, preferably lactated Ringer solution. Start ORS as soon as the patient can safely drink and continue replacing stool losses.
Continue breastfeeding and resume feeding as tolerated. Monitor ongoing stool losses, urine output, electrolytes and glucose when clinically indicated.
Prevention
Pharmacological Prevention
Killed oral cholera vaccines are used in endemic and outbreak settings together with safe water, sanitation and hygiene.
Mass preventive antibiotic administration during outbreaks is discouraged because it has no proven benefit for spread and can select resistance.
Zinc is a treatment adjunct for eligible children with acute diarrhea. It does not replace ORS or serve as routine cholera prophylaxis.
No effective chemoprophylaxis for travelers routinely recommended
For US travelers aged 2–64 years visiting areas with active transmission, CDC recommends the live oral CVD 103-HgR vaccine. Safe food and water practices remain important.
Non-pharmacological Prevention
Access to clean water and improved sanitation to prevent fecal-oral transmission
Proper hand hygiene especially after using the toilet and before eating
Safe food preparation and storage to avoid contamination
Public health measures including surveillance and outbreak control
Health education on avoiding contaminated water sources
Outcome & Complications
Complications
Hypovolemic shock from rapid fluid loss
Acute kidney injury due to severe dehydration
Electrolyte imbalances causing cardiac arrhythmias
Seizures or altered consciousness warrant checking glucose and sodium, especially in children. Potassium loss can cause muscle weakness and arrhythmias.
Death if untreated or in resource-limited settings
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Cholera (Vibrio cholerae) versus Enterotoxigenic Escherichia coli (ETEC) infection
Cholera (Vibrio cholerae) | Enterotoxigenic Escherichia coli (ETEC) infection |
|---|---|
Comma-shaped, gram-negative rod producing cholera toxin | ETEC produces heat-labile toxin (increases cAMP), heat-stable toxin (increases cGMP), or both. |
Contaminated water sources in endemic regions with poor sanitation | Contaminated food or water in travelers to endemic areas |
Profuse, watery 'rice-water' diarrhea causing severe dehydration | Mild to moderate watery diarrhea, often self-limited |
Confirm by culture and serogrouping or appropriate molecular testing. TCBS colony appearance alone cannot identify a toxigenic strain. | Detection of heat-labile or heat-stable toxin genes by PCR |
Cholera (Vibrio cholerae) versus Rotavirus infection
Cholera (Vibrio cholerae) | Rotavirus infection |
|---|---|
Cholera occurs at any age. Exposure, prior immunity and physiological reserve affect severity. | Primarily affects infants and young children |
Sudden watery diarrhea can be accompanied by vomiting. Fever and bloody stools are atypical. | Fever, vomiting, and watery diarrhea lasting 3-8 days |
Stool culture with serogroup identification or appropriate PCR can confirm cholera. Public health laboratories can characterize toxigenicity. | Detection of viral antigen in stool by enzyme immunoassay |
Cholera (Vibrio cholerae) versus Shigellosis
Cholera (Vibrio cholerae) | Shigellosis |
|---|---|
Non-invasive gram-negative curved rod producing enterotoxin | Gram-negative rod causing invasive colitis |
Profuse nonbloody watery stool may contain flecks of mucus, giving a rice-water appearance. | Inflammatory diarrhea can progress to bloody, mucoid stools with fever, cramps or tenesmus. |
Stool culture with serogroup identification or appropriate PCR can confirm cholera. Public health laboratories can characterize toxigenicity. | Positive stool culture for Shigella species |
Cholera (Vibrio cholerae) versus Giardiasis
Cholera (Vibrio cholerae) | Giardiasis |
|---|---|
Gram-negative bacterium producing enterotoxin | Flagellated protozoan parasite |
Acute profuse watery diarrhea without malabsorption | Chronic, foul-smelling, fatty diarrhea with malabsorption |
Stool culture with serogroup identification or appropriate PCR can confirm cholera. Public health laboratories can characterize toxigenicity. | Stool antigen or nucleic acid tests detect Giardia. Microscopy can identify cysts or trophozoites. |
Cholera (Vibrio cholerae) versus Clostridium difficile infection
Cholera (Vibrio cholerae) | Clostridium difficile infection |
|---|---|
Exposure to contaminated water or food in endemic areas | Recent antibiotic use or hospitalization |
Profuse watery diarrhea without colitis or pseudomembranes | Watery diarrhea with abdominal pain and possible pseudomembranous colitis |
Stool culture with serogroup identification or appropriate PCR can confirm cholera. Public health laboratories can characterize toxigenicity. | In a symptomatic patient, NAAT detects toxin genes whereas toxin immunoassay detects toxin protein. A positive NAAT alone can reflect colonization. |